STOCK TITAN

CVI and Heights disclose 8.2% Aptevo (APVO) stake via warrants in 13G/A

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Aptevo Therapeutics Inc. received an amended Schedule 13G filing showing that CVI Investments, Inc. and Heights Capital Management, Inc. report beneficial ownership of 83,854 shares of Aptevo common stock, or 8.2% of the class. The position consists entirely of shares issuable upon exercise of warrants. These warrants are subject to a 9.99% beneficial ownership cap, limiting exercisability if ownership would exceed that threshold. Heights Capital Management, Inc., as investment manager to CVI Investments, Inc., may share voting and dispositive power over these shares, though both reporting persons disclaim beneficial ownership beyond their pecuniary interest and state the holdings are not for the purpose of influencing control.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: With respect to Row 6 and Row 8 above, Heights Capital Management, Inc. is the investment manager to CVI Investments, Inc. and as such may exercise voting and dispositive power over the shares reported as beneficially owned by CVI Investments, Inc. herein.


SCHEDULE 13G




Comment for Type of Reporting Person: With respect to Row 6 and Row 8 above, Heights Capital Management, Inc. is the investment manager to CVI Investments, Inc. and as such may exercise voting and dispositive power over the shares reported as beneficially owned by CVI Investments, Inc. herein.


SCHEDULE 13G



CVI Investments, Inc.
Signature:/s/ Sarah Travis
Name/Title:Sarah Travis, Assistant General Counsel and Assistant Secretary of Heights Capital Management, Inc.
Date:02/10/2026
Heights Capital Management, Inc.
Signature:/s/ Sarah Travis
Name/Title:Sarah Travis, Assistant General Counsel and Assistant Secretary
Date:02/10/2026

Comments accompanying signature: Heights Capital Management, Inc. serves as authorized agent of CVI Investments, Inc. pursuant to a Limited Power of Attorney, a copy of which was previously filed.
Exhibit Information

EXHIBIT INDEX EXHIBIT DESCRIPTION 24 Limited Power of Attorney* 99 Joint Filing Agreement* * Previously filed

FAQ

What ownership stake in APVO does CVI Investments report on this Schedule 13G/A?

CVI Investments, Inc. reports beneficial ownership of 83,854 Aptevo Therapeutics shares, representing 8.2% of the common stock. These shares are issuable upon exercise of warrants, rather than currently outstanding stock directly held.

Who are the reporting persons in this Aptevo (APVO) Schedule 13G/A filing?

The filing lists CVI Investments, Inc. and Heights Capital Management, Inc. as reporting persons. Heights Capital Management, Inc. is the investment manager to CVI Investments, Inc. and may exercise voting and dispositive power over the reported Aptevo shares.

How is the 8.2% ownership in Aptevo (APVO) calculated in this filing?

The filing states the reporting persons beneficially own 83,854 shares, which is 8.2% of Aptevo’s common stock. It references a company Form 10-Q indicating 936,139 shares outstanding after a 1-for-18 reverse stock split.

What type of securities do CVI and Heights hold related to Aptevo (APVO)?

Their position consists of shares issuable upon exercise of warrants. The filing clarifies that the 83,854 shares reported as beneficially owned are not currently outstanding stock, but would be issued if the warrants are exercised.

Is there a beneficial ownership limitation on the Aptevo (APVO) warrants held?

Yes. The warrants are not exercisable to the extent exercise would cause the reporting persons and affiliates to beneficially own more than 9.99% of Aptevo’s shares, effectively capping their exercisable ownership.

Do CVI and Heights intend to influence control of Aptevo (APVO) with this stake?

The certification states the securities were not acquired and are not held for the purpose of changing or influencing control of Aptevo. They also are not held in connection with any transaction having that control-related purpose.

How do Heights Capital and CVI describe their beneficial ownership of Aptevo (APVO)?

The filing notes Heights Capital Management, Inc. may be deemed beneficial owner as investment manager to CVI. However, each reporting person disclaims beneficial ownership of the shares beyond their pecuniary interest in the Aptevo position.
Aptevo Therapeutics Inc

NASDAQ:APVO

APVO Rankings

APVO Latest News

APVO Latest SEC Filings

APVO Stock Data

6.70M
998
Biotechnology
Pharmaceutical Preparations
Link
United States
SEATTLE